An economic analysis of cancer drug pricing: Market failures, policy challenges, and equity implications

Shimeng Qu ()

International Journal of Innovative Research and Scientific Studies, 2025, vol. 8, issue 4, 500-506

Abstract: The global cost of cancer treatment has escalated, with drug prices becoming a major barrier to access and sustainability in healthcare systems. This paper examines the economic drivers behind these high prices, including patent protections, market monopolies, inelastic demand, information asymmetry, and opaque R&D costs. Drawing on economic theory and recent literature, it finds that cancer drugs are often priced well above their clinical value. Pharmaceutical firms typically recover R&D costs rapidly but maintain high prices, generating profit margins disproportionate to therapeutic outcomes. Cross-country comparisons reveal stark disparities in affordability. In some middle-income countries, patients must work over two weeks on minimum wage to afford a single dose. These pricing practices place significant strain on individuals and healthcare budgets, especially where negotiating power is limited. The paper argues that current pricing models are economically inefficient and socially unjust. It recommends key reforms: reducing market exclusivity periods, implementing value-based pricing aligned with clinical outcomes, and enforcing transparency in R&D spending and pricing structures. These steps are critical to improving drug affordability, advancing equity, and supporting responsible innovation in cancer care.

Keywords: Cancer drug pricing; health policy reform; market failure; pharmaceutical economics; value-based pricing. (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://ijirss.com/index.php/ijirss/article/view/7877/1723 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:aac:ijirss:v:8:y:2025:i:4:p:500-506:id:7877

Access Statistics for this article

International Journal of Innovative Research and Scientific Studies is currently edited by Natalie Jean

More articles in International Journal of Innovative Research and Scientific Studies from Innovative Research Publishing
Bibliographic data for series maintained by Natalie Jean ().